Announcements

Return to Dashboard
Press Releases

BioPorto A/S

BioPorto A/S initiates a rights issue with pre-emptive rights for its existing shareholders and proceeds of up to approximately DKK 59.4 million with approximately DKK 16.6 million pre-subscribed pursuant to advance commitments

Tue, 30 May 2023 15:27 GMT

BioPorto A/S

Increase in share capital following exercise of warrants – Notice of changes in share capital and voting rights pursuant to section 32 of the Danish Capital Markets Act

Tue, 23 May 2023 18:02 GMT

BioPorto A/S

BioPorto Announces Interim Results for the First Three Months of 2023

Wed, 10 May 2023 06:20 GMT

BioPorto A/S

BioPorto A/S to Host Quarterly Earnings Webcast and Analyst Call

Wed, 03 May 2023 06:53 GMT

BioPorto A/S

Resolutions of the General Meeting of BioPorto A/S

Thu, 27 Apr 2023 14:14 GMT

BioPorto A/S

Grant of Warrants

Tue, 25 Apr 2023 20:12 GMT

BioPorto A/S

Notice convening the Annual General Meeting in BioPorto A/S

Wed, 05 Apr 2023 06:35 GMT

BioPorto A/S

BioPorto Announces Annual Results for the Year ended December 31, 2022

Thu, 30 Mar 2023 06:48 GMT

BioPorto A/S

BioPorto Announces Financial Guidance for 2023

Wed, 29 Mar 2023 20:51 GMT

BioPorto A/S

US healthcare executive Dr. Ninfa Saunders, DHA, MVA, MSN, FACHE and other Board members to be nominated at general meeting; Chris Lindop not standing for re-election.

Wed, 29 Mar 2023 20:02 GMT

Follow this link to view additional historical announcements.